- News & Analysis
Page 635
Mersana makes $75m in IPO
The cancer drug conjugate developer floated in the middle of its range, in an offering that provided exits to Takeda subsidiary Millennium Pharmaceuticals and Pfizer.
Jun 29, 2017VarmX keeps cash flowing
The spinout of Leiden University Medical Center is working on a treatment that prevents acute bleeding in patients taking medication for thrombosis.
Jun 29, 2017Merck and Illumina map out $8m SerImmune round
Illumina Ventures has led a series A round for SerImmune, which will use the funding to enhance its immune system mapping platform.
Jun 27, 2017Merck and Illumina map out $8m SerImmune round
Illumina Ventures has led a series A round for SerImmune, which will use the funding to enhance its immune system mapping platform.
Jun 25, 2017Vineti wins series A funding
Founding investors GE Ventures and Mayo Clinic Ventures have taken part in a $13.8m round for Vineti, which aims to increase access to gene and cellular therapies.
Jun 23, 2017Woodford joins Dementia Discovery Fund backers
Woodford Investment Management has supplied approximately $19m for the fund, whose backers include Biogen, GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Pfizer, Takeda and Astex.
Jun 23, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2025 Mawsonia Ltd. All rights reserved.test regLogin